Ignite Creation Date:
2025-12-25 @ 12:22 AM
Ignite Modification Date:
2025-12-25 @ 10:25 PM
Study NCT ID:
NCT03564158
Status:
COMPLETED
Last Update Posted:
2019-01-10
First Post:
2018-04-30
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Evaluate Effects of Meropenem-Vaborbactam on QT/QTc in Healthy Volunteers
Sponsor:
Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-05-01
Start Date Type:
ACTUAL
Primary Completion Date:
2018-11-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-11-19
Completion Date Type:
ACTUAL
First Submit Date:
2018-04-30
First Submit QC Date:
None
Study First Post Date:
2018-06-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-01-09
Last Update Post Date:
2019-01-10
Last Update Post Date Type:
ACTUAL